Chiron Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Emeryville CA United States (1981)
Status: Acquired by Novartis (2006)

Organization Overview

First Clinical Trial
1997
NCT00003126
First Marketed Drug
1992
aldesleukin (Proleukin)
First NDA Approval
1992
aldesleukin (Proleukin)
Last Known Activity
2006

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Biocine | CHIRON | Chiron company: Clinical Research and Medical Affairs | Chiron Corporation | Chiron s.r.l. Beijing Representative Office